Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Pediatric Trials

Cincinnati, Ohio

CNS trials open to children and teens in Cincinnati, OH

34 CNS studies open to children and teens are recruiting participants at sites in Cincinnati as of November 18, 2026, according to ClinicalTrials.gov. CNS Pediatric Trials can help you understand your options and connect with a study team.

Call (888) 927-9530
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Cincinnati at a glance

  • 34 studies are recruiting at a site in Cincinnati.
  • By phase: Phase 1 (1), Phase 3 (15), Phase 4 (6), No phase (9), Observational (3). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (19), university, hospital or other (15).
  • By research area: Migraine (13), ADHD (8), Depression (5), Schizophrenia (5), Epilepsy (2), Bipolar Disorder (1).
  • Most recent update to one of these records: November 13, 2026.

ADHD studies recruiting in Cincinnati

Basic details from each study's public record (the 30 most recently updated of 34). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. AWARE: Management of ADHD in Autism Spectrum Disorder

    • Phase 4
    • Ages 4 to 17
    • All sexes
    Sponsor
    Daniel Coury
    Study site
    Cincinnati Children's Hospital Medical Center
    Registry record
    NCT05916339 · updated
  2. Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

    • Phase 4
    • From 48 months, up to 69 months
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Study site
    Cincinnati Children's Hospital and Medical Center
    Registry record
    NCT04781140 · updated
  3. Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder

    • Phase 4
    • Ages 8 to 12
    • All sexes
    Sponsor
    Donald Gilbert, MD, MS, FAAN, FAAP
    Study site
    Cincinnati Children's Hospital Medical Center
    Registry record
    NCT04421248 · updated
  4. Treating Young Children With Attention Deficit Hyperactivity Disorder

    • Phase 4
    • Ages 3 to 5
    • All sexes
    Sponsor
    Children's Hospital Medical Center, Cincinnati
    Study site
    Cincinnati Children's Hospital Medical Center
    Registry record
    NCT07300956 · updated
  5. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

    • Observational
    • Ages 0 to 20
    • All sexes
    Sponsor
    Duke University
    Study site
    Cincinnati Childrens Hospital Medical Center
    Registry record
    NCT04278404 · updated
  6. Impact of Short and Mistimed Sleep on Adolescents With ADHD: The Adolescent Attention and Circadian Timing Study

    • No phase
    • Ages 13 to 17
    • All sexes
    Sponsor
    Children's Hospital Medical Center, Cincinnati
    Study site
    Cincinnati Children's Hospital Medical Center
    Registry record
    NCT07684417 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Cincinnati, OH on ClinicalTrials.gov.

Depression studies recruiting in Cincinnati

  1. Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

    • No phase
    • Ages 12 to 22
    • All sexes
    Sponsor
    Michigan State University
    Study site
    Cincinnati Children's Hospital Medical Center
    Registry record
    NCT06232304 · updated
  2. Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

    • Phase 3
    • Ages 10 to 17
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Study site
    University of Cincinnati Medical Center
    Registry record
    NCT06372964 · updated
  3. TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

    • Observational
    • From 18 months, up to 11 years
    • All sexes
    Sponsor
    State University of New York at Buffalo
    Study site
    Cincinnati Children's Hospital Medical Center
    Registry record
    NCT07048574 · updated
  4. A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    University of Cincinnati
    Registry record
    NCT07227454 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Cincinnati, OH on ClinicalTrials.gov.

Epilepsy studies recruiting in Cincinnati

  1. A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

    • Phase 3
    • From 1 day, up to 18 years
    • All sexes
    Sponsor
    Praxis Precision Medicines
    Study site
    Praxis Research Site
    Registry record
    NCT07019922 · updated
  2. Epilepsy Journey-An Executive Functioning Intervention for Teens With Epilepsy

    • No phase
    • Ages 13 to 17
    • All sexes
    Sponsor
    Children's Hospital Medical Center, Cincinnati
    Study site
    Cincinnati Children's Hospital Medical Center
    Registry record
    NCT06608966 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Cincinnati, OH on ClinicalTrials.gov.

Migraine studies recruiting in Cincinnati

  1. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study site
    Cincinnati Children's Hospital Medical Center
    Registry record
    NCT04649242 · updated
  2. Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study site
    Cincinnati Children's Hospital
    Registry record
    NCT04743141 · updated
  3. Overlapping Pain Trajectory Study

    • Observational
    • Ages 10 to 19
    • All sexes
    Sponsor
    Children's Hospital Medical Center, Cincinnati
    Study site
    Cincinnati Children's Hospital
    Registry record
    NCT05752396 · updated
  4. A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    H. Lundbeck A/S
    Study site
    Cincinnati Children's Hospital Medical Center-Burnet Campus
    Registry record
    NCT04965675 · updated
  5. Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study site
    Cincinnati Children's Hospital Medical Center
    Registry record
    NCT05156398 · updated
  6. A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    H. Lundbeck A/S
    Study site
    Cincinnati Children's Hospital Medical Center-Burnet Campus
    Registry record
    NCT05164172 · updated
  7. A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    H. Lundbeck A/S
    Study site
    Cincinnati Children's Hospital Medical Center-Burnet Campus
    Registry record
    NCT05897320 · updated
  8. A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Study sites
    Cincinnati Childrens Hospital Medical Center /ID# 258070 · Patient Priority Clinical Sites, LLC /ID# 247535
    Registry record
    NCT05711394 · updated
  9. A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

    • Phase 1
    • Ages 6 to 11
    • All sexes
    Sponsor
    Pfizer
    Study site
    Cincinnati Children's Hospital Medical Center
    Registry record
    NCT06995729 · updated
  10. Responding With Evidence and Access for Childhood Headaches

    • No phase
    • Ages 10 to 17
    • All sexes
    Sponsor
    Children's Hospital Medical Center, Cincinnati
    Study site
    Cincinnati Children's Hospital Medical Center
    Registry record
    NCT05889624 · updated
  11. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Study sites
    Cincinnati Childrens Hospital Medical Center /ID# 244689 · Headache Center of Hope /ID# 242645 · Patient Priority Clinical Sites, LLC /ID# 238485
    Registry record
    NCT05125302 · updated
  12. Supraspinal Processing of Sensory Aspects of Pain

    • No phase
    • Ages 10 to 17
    • All sexes
    Sponsor
    Children's Hospital Medical Center, Cincinnati
    Study site
    Cincinnati Children's Hospital
    Registry record
    NCT05814497 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Cincinnati, OH on ClinicalTrials.gov.

Schizophrenia studies recruiting in Cincinnati

  1. A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

    • Phase 3
    • Ages 13 to 17
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    University of Cincinnati Dept of Psychiatry and Behavioral Neuroscience
    Registry record
    NCT07288567 · updated
  2. A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

    • Phase 3
    • Ages 5 to 17
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    University of Cincinnati Cancer Institute
    Registry record
    NCT07424404 · updated
  3. Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

    • Phase 3
    • Ages 5 to 17
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Study site
    University of Cincinnati Medical Center
    Registry record
    NCT06229210 · updated
  4. Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

    • Phase 4
    • Ages 12 to 17
    • All sexes
    Sponsor
    Vanda Pharmaceuticals
    Study site
    Vanda Investigational Site
    Registry record
    NCT05648591 · updated
  5. Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

    • Phase 3
    • Ages 10 to 17
    • All sexes
    Sponsor
    Alkermes, Inc.
    Study site
    Alkermes Investigator Site
    Registry record
    NCT05303064 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Cincinnati, OH on ClinicalTrials.gov.

Bipolar disorder studies recruiting in Cincinnati

  1. Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents

    • No phase
    • Ages 12 to 21
    • All sexes
    Sponsor
    University of California, Los Angeles
    Study site
    University of Cincinnati College of Medicine
    Registry record
    NCT06920940 · updated

Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Cincinnati, OH on ClinicalTrials.gov.

Ask about studies near Cincinnati

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Ohio

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.

CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9530

or send a short form

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?

Call